Safety and Efficacy of Empagliflozin as Add-On Therapy to GLP-1 Receptor Agonist (Liraglutide) in Japanese Patients with Type 2 Diabetes Mellitus: A Randomised, Double-Blind, Parallel-Group Phase 4 Study

Receptor Agonist ◽

Japanese Patients ◽

Double Blind ◽

Safety And Efficacy ◽

Efficacy and safety of pioglitazone added to alogliptin in Japanese patients with type 2 diabetes mellitus: a multicentre, randomized, double-blind, parallel-group, comparative study

10.1111/dom.12555 ◽

2015 ◽

Vol 17 (12) ◽

pp. 1198-1201 ◽

Cited By ~ 5

Author(s):

K. Kaku ◽

M. Katou ◽

M. Igeta ◽

T. Ohira ◽

H. Sano

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Comparative Study ◽

Japanese Patients ◽

Efficacy And Safety ◽

Double Blind ◽

Efficacy and safety of teneligliptin added to canagliflozin monotherapy in Japanese patients with type 2 diabetes mellitus: A multicentre, randomized, double‐blind, placebo‐controlled, parallel‐group comparative study

10.1111/dom.13079 ◽

2017 ◽

Vol 20 (2) ◽

pp. 453-457 ◽

Cited By ~ 15

Author(s):

Takashi Kadowaki ◽

Nobuya Inagaki ◽

Kazuoki Kondo ◽

Kenichi Nishimura ◽

Genki Kaneko ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Comparative Study ◽

Japanese Patients ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Sitagliptin monotherapy has better effect on insulinogenic index than glimepiride monotherapy in Japanese patients with type 2 diabetes mellitus: a 52-week, multicenter, parallel-group randomized controlled trial

Diabetology & Metabolic Syndrome ◽

10.1186/s13098-016-0131-y ◽

2016 ◽

Vol 8 (1) ◽

Cited By ~ 5

Author(s):

Yaeko Kondo ◽

◽

Norio Harada ◽

Akihiro Hamasaki ◽

Shizuka Kaneko ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Randomized Controlled Trial ◽

Controlled Trial ◽

Japanese Patients ◽

Insulinogenic Index ◽

Randomized Controlled ◽

Effects of once-daily teneligliptin on 24-h blood glucose control and safety in Japanese patients with type 2 diabetes mellitus: a 4-week, randomized, double-blind, placebo-controlled trial

10.1111/j.1463-1326.2012.01662.x ◽

2012 ◽

Vol 14 (11) ◽

pp. 1040-1046 ◽

Cited By ~ 51

Author(s):

T. Eto ◽

S. Inoue ◽

T. Kadowaki

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Controlled Trial ◽

Blood Glucose Control ◽

Japanese Patients ◽

Double Blind ◽

Once Daily ◽

Double Blind Placebo

Efficacy and safety of canagliflozin in combination with insulin: a double-blind, randomized, placebo-controlled study in Japanese patients with type 2 diabetes mellitus

Cardiovascular Diabetology ◽

10.1186/s12933-016-0407-4 ◽

2016 ◽

Vol 15 (1) ◽

Cited By ~ 35

Author(s):

Nobuya Inagaki ◽

Shin-ichi Harashima ◽

Nobuko Maruyama ◽

Yutaka Kawaguchi ◽

Maki Goda ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Japanese Patients ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind

Efficacy and safety of dapagliflozin as a monotherapy for type 2 diabetes mellitus in Japanese patients with inadequate glycaemic control: a phase II multicentre, randomized, double-blind, placebo-controlled trial

10.1111/dom.12047 ◽

2013 ◽

Vol 15 (5) ◽

pp. 432-440 ◽

Cited By ~ 90

Author(s):

K. Kaku ◽

S. Inoue ◽

O. Matsuoka ◽

A. Kiyosue ◽

H. Azuma ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Glycaemic Control ◽

Controlled Trial ◽

Japanese Patients ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Sustained-release versus immediate-release glipizide for treatment of type 2 diabetes mellitus in chinese patients: A randomized, double-blind, double-dummy, parallel-group, 12-week clinical study

Clinical Therapeutics ◽

10.1016/j.clinthera.2006.09.010 ◽

2006 ◽

Vol 28 (9) ◽

pp. 1318-1326 ◽

Cited By ~ 4

Author(s):

Sheng-Hwu Hsieh ◽

Jen-Der Lin ◽

Hung-Yu Cheng ◽

Cheng Ho ◽

Miaw-Jene Liou

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Clinical Study ◽

Immediate Release ◽

Chinese Patients ◽

Double Blind ◽

Parallel Group ◽

Group 12

Randomized, placebo‐controlled, double‐blind glycemic control trial of novel sodium‐dependent glucose cotransporter 2 inhibitor ipragliflozin in Japanese patients with type 2 diabetes mellitus

Journal of Diabetes Investigation ◽

10.1111/jdi.12156 ◽

2013 ◽

Vol 5 (4) ◽

pp. 382-391 ◽

Cited By ~ 59

Author(s):

Atsunori Kashiwagi ◽

Kenichi Kazuta ◽

Satoshi Yoshida ◽

Itsuro Nagase

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Glycemic Control ◽

Japanese Patients ◽

Double Blind ◽

Sodium Dependent

Efficacy and safety of alogliptin in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, dose-ranging comparison with placebo, followed by a long-term extension study

Current Medical Research and Opinion ◽

10.1185/03007995.2011.599371 ◽

2011 ◽

Vol 27 (9) ◽

pp. 1781-1792 ◽

Cited By ~ 57

Author(s):

Yutaka Seino ◽

Tetsuya Fujita ◽

Shinzo Hiroi ◽

Masashi Hirayama ◽

Kohei Kaku

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Japanese Patients ◽

Extension Study ◽

Efficacy And Safety ◽

Double Blind ◽

Dose Ranging

Safety and efficacy of metformin up-titration in Japanese patients with type 2 diabetes mellitus treated with vildagliptin and low-dose metformin

Expert Opinion on Pharmacotherapy ◽

10.1080/14656566.2017.1404576 ◽

2017 ◽

Vol 18 (18) ◽

pp. 1921-1928 ◽

Cited By ~ 2

Author(s):

Luka Suzuki ◽

Akio Kanazawa ◽

Hirotsugu Uzawa ◽

Yusuke Osonoi ◽

Atushi Masuyama ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Low Dose ◽

Japanese Patients ◽

Safety And Efficacy